PRESS-RELEASE ·Filed Apr 30, 2026

IRTC

iRhythm
BULLISH
Impact 8/10
Horizondays Processed5mo ago WireGlobeNewswire
Press release: earnings
Actionable Insight ▲ Bullish

The strong beat and raised guidance signal accelerating volume adoption and operating leverage. Monitor upcoming 10-Q for cash flow trajectory and litigation expense trends; the stock may gap up on the guidance raise and margin inflection.

DirectionBullish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
IRTC ▼ -2.84% at T+60d
LONG call ✗ call lost -2.84% · α vs SPY -5.91% · entry $120.80 → $117.37
Entry anchored
Apr 30, 03:59 PM ET
via exchange tick
T+1d
-1.34%
call -1.34% · α -1.00%
$119.18
settled 5mo ago
T+5d
+3.37%
call +3.37% · α +1.02%
$124.87
settled 5mo ago
T+20d
-9.63%
call -9.63% · α -14.91%
$109.17
settled 4mo ago
T+60d
-2.84%
call -2.84% · α -5.91%
$117.37
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

iRhythm reported Q1 2026 revenue of $199.4M (+25.7% YoY) and GAAP EPS of -$0.43, beating consensus estimates of $194.1M and -$0.64. The company raised full-year 2026 revenue guidance to $875M-$885M and adjusted EBITDA margin to 12-13%, driven by volume growth and margin expansion across cardiology and primary care channels.

Key Financial Metrics

EPS
$-0.43
est $-0.64 · +32.8%
Revenue
$199.4M
est $194.1M · +2.7% · +25.7% YoY
Rating
strong beat
Guidance
$875M-$885M
raised
Free Cash Flow
-$33.1M
Gross Margin
70.9%

Key Facts

  • Q1 2026 revenue $199.4M vs consensus $194.1M (+2.7% beat)
  • GAAP EPS -$0.43 vs consensus -$0.64 (32.8% beat on a loss basis)
  • Revenue grew 25.7% YoY from $158.7M
  • Gross margin expanded 210 bps to 70.9%
  • Net loss improved to $13.9M from $30.7M YoY
  • Adjusted EBITDA turned positive to $14.1M from -$2.6M YoY
  • Raised FY2026 revenue guidance to $875M-$885M (prior undisclosed)
  • Raised FY2026 adjusted EBITDA margin guidance to 12-13%
  • Unrestricted cash and marketable securities $549.6M

Financial Impact

Revenue beat by ~$5.3M; EPS beat by $0.21 vs consensus; guidance raised by undisclosed amount

revenuegross marginnet lossadjusted EBITDAguidance

Risk Factors

  • Patent litigation costs ($3.7M in Q1) remain an overhang
  • Still GAAP-unprofitable with net loss of $13.9M
  • Operating cash flow negative at -$26.2M in Q1

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
90% bullish (21 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3285439
18 reports for IRTC
Performance horizon
88% Hit rate 7 of 8 directional calls best @ T+60▲ +16.97%Feb 24, 2026
Filters
Rows
Reports for IRTC — sortable, filterable
TypeNow
Aug 11, 2026
7w ago
Insider Cluster
BEARISH ★ 5/10
$125.35 $112.88▲ +9.95%▲ +8.05%$110.37 (+11.95%)
Aug 11, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$125.35 $112.88▼ −9.95%▼ −8.05%$110.37 (−11.95%)
Aug 4, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$127.13 $122.35▼ −3.76%▼ −2.52%$110.37 (−13.18%)
Jul 6, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$126.03 $117.17▼ −7.03%▼ −6.46%$110.37 (−12.43%)
Jun 15, 2026
15w ago
8-K
BEARISH ★ 6/10
$108.84 $112.55▼ −3.41%▼ −3.21%$110.37 (−1.41%)
Jun 5, 2026
17w ago
8-K
BULLISH ★ 5/10
$108.11 $126.03▲ +16.58%▲ +14.72%$110.37 (+2.10%)
May 28, 2026
18w ago
8-K
NEUTRAL ★ 2/10
$115.61 $118.89▲ +2.84%▲ +5.98%$110.37 (−4.53%)
May 11, 2026
20w ago
144
NEUTRAL ★ 2/10
$118.31 $113.94▼ −3.69%▼ −1.97%$110.37 (−6.71%)
May 4, 2026
21w ago
Insider Cluster
NEUTRAL ★ 2/10
$119.18 $109.17▼ −8.40%▼ −14.04%$110.37 (−7.39%)
Apr 30, 2026
22w ago
Press Release
BULLISH ★ 8/10
$120.80 $109.17▼ −9.63%▼ −14.91%$110.37 (−8.63%)
Showing 10 of 18

US Market Status

Market Closed — Opens Mon (64h 8m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 30, 2026